Welcome to Psoriasis Guide歡迎銀屑病指南
Psoriasis Article銀屑病的文章
. 。 For a permanent link to this article, or to bookmark it for further reading,為永久鏈接此文章，或以書籤，它為進一步讀， click here點擊這裡 . 。
What Can Psoriasis Medicine Do for Psoriasis Patients?有什麼可以銀屑病的中醫藥為銀屑病患者？
from : 來自 ：There are a lot of different kinds of psoriasis medicine for the treatment of psoriasis, and these are available in many different forms.有很多不同類型的銀屑病醫藥治療銀屑病，這些都是可在許多不同的形式。 Psoriasis medicine is actually formulated to help treat the lesions, scales, dry skin and flakes that are the trademarks of the disease, but it does not really cure the person of psoriasis.銀屑病中醫，其實是制定，以幫助治療病灶，鱗片，皮膚乾燥和箔條是商標疾病，但它並沒有真正治療的人銀屑病。 Since psoriasis still has no known cure, and people who have it basically carry the disease with them for the rest of their lives, the use of psoriasis medicine on psoriasis patients is merely for the purpose of keeping the disease at a level that is easily manageable so that it does not hinder a person from living a normal life.由於銀屑病仍沒有已知的治療，和人民誰也基本上進行疾病與他們渡過餘生，使用銀屑病的中藥對銀屑病患者只是為目的的飼養疾病在一定的水平上是容易管理因此，它不妨礙一個人生活過正常的生活。
The choice of psoriasis medicine is dependent on the severity of a person's psoriasis lesions and flakes, and medications are selected based on how well they work on different individuals.選擇銀屑病的中醫藥是依賴於的嚴重性，一個人的銀屑病病變及片，及藥物選擇的基礎上如何，以及他們的工作，不同的個人。 These different kinds of psoriasis medicine come in topical and systemic forms, and they are also available in a form called photo therapy or light therapy, where the person is subjected to UV rays either from the sun or an artificial source inside the clinic or medical facility.這些不同種類的銀屑病的中醫藥來在局部和全身的形式，他們也可以在某種形式的所謂照片療法或光療法，如該人是受到紫外線無論是從太陽或一人工源內的診所或醫療設施。 There are many different ways that a person can be treated for such a bothersome disease, and once a program for treatment is started, the patient needs to be vigilant to ensure that he is treated continually.有許多不同的方式，一個人可以治療這種疾病的困擾，一旦一個程序處理是開始，病人的需要，必須提高警覺，以確保他是治療不斷。
Of course, over time, the psoriasis medicine that a person uses may soon become ineffective due to the increased immunity of the disease after a prolonged period of time.當然，隨著時間的推移，銀屑病中醫認為，一個人使用可能很快變得無效，由於增加免疫功能的疾病經過長時間的一段時間。 Once the effects of such treatments begin to diminish in effect, patients may need to find another kind of psoriasis medicine for their psoriasis problems.一旦效果，例如治療開始減少在的效果，病人可能需要找到另一種銀屑病的中醫藥為他們銀屑病的問題。 Maintenance of some kind of treatment is essential since the recurrence of the breakouts of psoriasis can have quite unsightly effects on a person's skin.維持某種形式的治療是必不可少的，因為復發的突破銀屑病可以有相當有礙觀瞻的影響，一個人的皮膚。 The appearance of flakes and lesions on a person's body can be easily controlled as long as the person who is afflicted by this condition takes his medication religiously.外觀箔條和病變的一個人的身體可以很容易地控制，只要人誰是受這個條件需服藥宗教。 He needs to apply the topical solutions and creams that are formulated to make these skin imperfections dissipate, and follow certain regimens that will help keep these flare ups from occurring.他需要申請的專題解決方案和面霜是制定，使這些皮膚不完善消散，並按照一定的regimens ，這將有助於保持這些耀斑的UPS的發生。
While the current list of treatments for psoriasis cannot eliminate the problem entirely from the person's system, there is now psoriasis medicine available for people who need it.雖然目前的名單治療銀屑病不能消除的問題，完全從人的制度，現在是銀屑病的中藥，供人誰需要它。 Even though psoriasis is a chronic problem, the right medicine will help sooth the discomfort that the illness brings.即使銀屑病是一種慢性問題，對症下藥，將有助於sooth不適，該疾病帶來的。 You can find out from your skin doctor about the kind of psoriasis medicine that is most effective in controlling your psoriasis problem.你可以找到從您的皮膚醫生對種銀屑病中醫是最有效地控制您的銀屑病問題。
Psoriasis News銀屑病新聞
Amgen's Enbrel in kids "concerning," FDA staff says - Reuters Amgen的enbrel在孩子“有關， ” FDA的工作人員說-路透社
WASHINGTON (Reuters) - US drug regulators are concerned about life-threatening complications in children taking Amgen Inc's drug Enbrel for psoriasis and other conditions, according to documents released on Monday. （華盛頓路透電） -美國藥物監管機構關心威脅生命的並發症，在兒童以不同的公司的藥物e nbrel為銀屑病和其他方面的情況，根據公佈的文件對週一。 Amgen, which markets the ... Amgen的，哪個市場...
Read more...閱讀更多...FDA Advisory Committee Unanimously Recommends Approval of Ustekinumab ... FDA的諮詢委員會的一致建議批准ustekinumab ... - Forbes -福布斯
HORSHAM, Pa., June 17 /PRNewswire/ -- Centocor, Inc. announced today that the Dermatologic and Ophthalmic Drugs Advisory Committee (DODAC) of the US Food and Drug Administration (FDA) has unanimously recommended the approval of ustekinumab, a new ...霍舍姆，賓夕法尼亞州， 6月17日/新華美通/ -c entocor，公司今天宣布，該皮膚科及眼科藥物諮詢委員會（ d odac）美國食品和藥物管理局（ F DA）已一致推薦批准u stekinumab，一個新的。 ..
Read more...閱讀更多...UPDATE: FDA Panel Recommends Approval For J&J Psoriasis Drug - CNN Money更新： FDA的專家小組建議批准強生公司銀屑病的藥物-有線電視新聞網的錢
unanimously recommended approval of a Johnson & Johnson (JNJ) drug proposed for treatment of severe-to-moderate psoriasis, but said more data is needed to determine whether the drug increases the risk of cancer and infections.一致推薦批准一項強生公司（ jnj ）建議的藥物治療重度到中度銀屑病，但他表示，更多的數據需要，以確定是否吸毒增加患癌症的風險和感染。 Despite those concerns ...儘管有這些關切...
Read more...閱讀更多...US panel backs proposed J&J psoriasis drug - Forbes美國支持小組的建議強生公司銀屑病的藥物-福布斯
SILVER SPRING, Md., (Reuters) - An experimental Johnson & Johnson drug should be approved for treating adults with moderate or severe psoriasis, a advisory panel unanimously ruled Tuesday.銀春，馬里蘭州（路透社） -實驗強生公司藥物應批准用於治療成人中度或重度銀屑病，諮詢小組一致裁定星期二。 The ability of the drug, ustekinumab, to relieve symptoms of ...能力的藥物， ustekinumab ，以紓緩症狀...
Read more...閱讀更多...J&J Wins US Panel's Backing for New Psoriasis Drug (Update2) - Bloomberg強生公司贏得美國小組的支持，為新的銀屑病藥物（ update2 ） -彭博
June 17 (Bloomberg) -- Johnson & Johnson won a US panel's unanimous backing to introduce a new drug for millions of adults with the skin disorder psoriasis. 6月17日（彭博） -強生公司贏得了美國小組的一致支持，以引進新的藥物以百萬計的成年人與皮膚疾病，銀屑病。 Outside advisers to the Food and Drug Administration recommended approval of the injectable ...外面的顧問，美國食品和藥物管理局建議批准注射...
Read more...閱讀更多...FDA Panel Recommends Approval For J&J Psoriasis Drug - CNN Money FDA的專家小組建議批准強生公司銀屑病的藥物-有線電視新聞網的錢
SILVER SPRING, Md. -(Dow Jones)- A US Food and Drug Administration panel on Tuesday voted to recommend approval for a proposed Johnson & Johnson (JNJ) drug to treat severe-to-moderate psoriasis, a skin disease that affects more than seven million ...銀春，馬里蘭州-（道瓊斯） -美國食品和藥物管理局事務委員會星期二表決建議批准為擬議的強生公司（j n j）藥物治療重症到中度銀屑病，皮膚疾病，影響多7000000 ...
Read more...閱讀更多...